PLoS ONE (Jan 2016)

A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in Candida Species.

  • Andrea Zito,
  • Carla Bromuro,
  • Giorgia Mandili,
  • Paola Chiani,
  • Alberto L Horenstein,
  • Fabio Malavasi,
  • Roberto Cauda,
  • Antonio Cassone,
  • Antonella Torosantucci

DOI
https://doi.org/10.1371/journal.pone.0148714
Journal volume & issue
Vol. 11, no. 2
p. e0148714

Abstract

Read online

There is a real medical need of new diagnostic tools for the early recognition of invasive Candida infections. We exploited a rather simple and rapid redox methodology to construct a bispecific monoclonal antibody (bsmAb) that combines a monoclonal antibody (mAb) directed against 1,3-β-D-glucan, a well-known, pan-fungal diagnostic biomarker, with a mAb recognizing MP65, a major immunogenic mannoprotein secreted by C.albicans and other Candida species. The bsmAb (MP65/bglu mAb) was successfully produced and purified at high yields and proved to bind and reveal simultaneously, with high sensitivity, the β-glucan and MP65 antigens in both purified and native forms. The MP65/bglu mAb is the first bispecific antibody generated against a fungal microorganism and may prove useful for the concurrent detection of different and clinically significant Candida biomarkers in patient sera.